By establishing a University Matched Endowment today, you can continue funding outstanding ARCS Foundation scholars permanently into the future.
University Matched Endowments
The minimum amount to establish a University Matched Endowment at OHSU, OSU, or UO is $100,000 (given by the donor).
The three research universities supported by ARCS Oregon - OHSU, OSU, and UO - allocate matching funds of $50,000.
An endowment may bear your name or the name of someone you choose to honor or memorialize.
The endowment funds a scholar in an approved ARCS Foundation Oregon department at the university designated by the Donor, ensuring that successive generations of graduate students selected by the department will receive three year awards totalling $18,000 to help them succeed in their research.
University Matched Endowment Agreements have been written and approved by ARCS Oregon board and our university partners.
Management of Endowments at the Universities
The endowment is invested and managed by our university partners (OHSU, OSU and UO). The endowments are 3-way agreements between:
ARCS Foundation Oregon
The respective university (OHSU, OSU, or UO)
Once the endowment is established, each individual endowment maintains a separate identity but is pooled with all university endowments for investment purposes.
The goal of an established endowment is to fund scholar awards from its investment returns. The ARCS Foundation Oregon Scholar Award funds an aggregate of $18,000 payable over 3 years.
Each university will provide an annual report on the endowment status and activity to the Donor.
An endowed Scholar Award may be funded by check or appreciated securities. To request more information about sponsoring an Endowed Scholar Award please EMAIL us.
Photo courtesy of Andie Petkus
Sydney Weber Boutros, ARCS Scholar, Behavioral Neuroscience, OHSU
Sunil Joshi, ARCS Scholar at OHSU, Receives Soros Fellowship
Sunil Joshi is the first at OHSU to receive the Paul and Daisy Soros Fellowship Award. The fellowship supports outstanding immigrants and children of immigrants who are pursuing a graduate education in the United States. Sunil's research interest covers intrinsic and extrinsic mechanisms of drug resistance in the setting of acute myeloid leukemia. He works with Brian J. Druker, MD, a world-recognized expert in cancer.